Use of a high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory AML: Proof of concept and clinical implementation of precision medicine Meeting Abstract
| Authors: | Shum, D.; Heaney, M.; Brentjens, R.; Maslak, P.; Jurcic, J.; Djaballah, H.; Frattini, M. G. |
| Abstract Title: | Use of a high-throughput screen of primary leukemia cells to personalize therapy for relapsed/refractory AML: Proof of concept and clinical implementation of precision medicine |
| Meeting Title: | AACR Special Conference on Hematologic Malignancies: Translating Discoveries to Novel Therapies |
| Journal Title: | Clinical Cancer Research |
| Volume: | 21 |
| Issue: | 17 Suppl. |
| Meeting Dates: | 2014 Sep 20-23 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-09-01 |
| Language: | English |
| ACCESSION: | WOS:000361386200024 |
| DOI: | 10.1158/1557-3265.hemmal14-a28 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: A28 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
